Sec Form 4 Filing - Ledda Ralf @ INVACARE CORP - 2021-04-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Ledda Ralf 2. Issuer Name and Ticker or Trading Symbol INVACARE CORP [ IVC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Sen VP/GM-EUR,Mid East&Africa (Last) (First) (Middle) ONE INVACARE WAY 3. Date of Earliest Transaction (MM/DD/YY) 04/05/2021 (Street) ELYRIA, OH44035 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Shares 04/05/2021 A 13,382 ( 1 ) A $ 0 104,793 ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to Buy) ( 3 ) ( 4 ) ( 4 ) Common Shares 51,433 51,433 ( 4 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Ledda Ralf ONE INVACARE WAY ELYRIA, OH44035 Sen VP/GM-EUR,Mid East&Africa Signatures /s/ Ralf Ledda, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated November 10, 2016, on file with the Commission 04/07/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents common shares vested under performance-based share awards granted under the Issuer's 2013 Equity Compensation Plan. ( 2 )Includes 30,334 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 1,680 of these restricted stock units vest on May 15, 2021; 8,872 of these restricted stock units vest in 1/2 increments on May 15, 2021 and May 15, 2022; 10,512 of these restricted stock units vest in 1/3 annual increments over three years commencing May 15, 2021; and 9,270 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2022. ( 3 )No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5. ( 4 )The reporting person holds previously reported options to buy 51,433 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between September 2, 2011 and March 16, 2017, at exercise prices between $12.15 to $24.45 per share, will expire between September 2, 2021 and March 16, 2027, and became exercisable between September 30, 2012 and February 19, 2020.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.